Home › Research › Caregiving
The economic burden of dementia in China, 1990-2030: implications for health policy
Xu J, Wang J, Wimo A, Fratiglioni L, Qiu C.. Bulletin of the World Health Organization, 2016-10-18
Topic: Risk, prevention and care in population studies
Plain-language summary
Objective To quantify and predict the economic burden of dementia in China for the periods 1990-2010 and 2020-2030, respectively, and discuss the potential implications for national public health policy. Methods Using a societal, prevalence-based, gross cost-of-illness approach and data from multiple sources, we estimated or predicted total annual economic costs of dementia in China. We included direct medical costs in outpatient and inpatient settings, direct non-medical costs - e.g. the costs of transportation - and indirect costs due to loss of productivity. We excluded comorbidity-related costs. Findings The estimated total annual costs of dementia in China increased from 0.9 billion United States dollars (US$) in 1990 to US$ 47.2 billion in 2010 and were predicted to reach US$ 69.0 billion in 2020 and US$ 114.2 billion in 2030. The costs of informal care accounted for 94.4%, 92.9% and 81.3% of the total estimated costs in 1990, 2000 and 2010, respectively. In China, population ageing and the increasing prevalence of dementia were the main drivers for the increasing predicted costs of dementia between 2010 and 2020, and population ageing was the major factor contributing to the growth of dementia costs between 2020 and 2030. Conclusion In China, demographic and epidemiological transitions have driven the growth observed in the economic costs of dementia since the 1990s. If the future costs of dementia are to be reduced, China needs a nationwide dementia action plan to develop an integrated health and social care system and to promote primary and secondary prevention.
What this study adds
Evidence grade: Low
In China, the yearly cost of dementia was estimated to rise from US$ 0.9 billion in 1990 to US$ 47.2 billion in 2010 and was predicted to reach US$ 114.2 billion by 2030, driven mainly by population ageing and rising dementia prevalence. Reported effect size: or 94.4; 92.9%; 81.3%.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Xu, J., Wang, J., Wimo, A., Fratiglioni, L., & Qiu, C. (2017). The economic burden of dementia in China, 1990-2030: implications for health policy. Bulletin of the World Health Organization. https://doi.org/10.2471/blt.15.167726
Vancouver
Xu J, Wang J, Wimo A, Fratiglioni L, Qiu C. The economic burden of dementia in China, 1990-2030: implications for health policy. Bulletin of the World Health Organization. 2017. doi:10.2471/blt.15.167726. PMID: 28053361.
BibTeX
@article{xu2017-28053361,
author = {Xu, J. and Wang, J. and Wimo, A. and Fratiglioni, L. and Qiu, C.},
title = {{The economic burden of dementia in China, 1990-2030: implications for health policy}},
journal = {Bulletin of the World Health Organization},
year = {2017},
doi = {10.2471/blt.15.167726},
pmid = {28053361},
url = {https://doi.org/10.2471/blt.15.167726}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- Findings The estimated total annual costs of dementia in China increased from 0.9 billion United States dollars (US$) in 1990 to US$ 47.2 billion in 2010 and were predicted to reach US$ 69.0 billion in 2020 and US$ 114.2 billion in 2030.
- The costs of informal care accounted for 94.4%, 92.9% and 81.3% of the total estimated costs in 1990, 2000 and 2010, respectively.
- In China, population ageing and the increasing prevalence of dementia were the main drivers for the increasing predicted costs of dementia between 2010 and 2020, and population ageing was the major factor contributing to the growth of dementia costs between 2020 and 2030.
- Conclusion In China, demographic and epidemiological transitions have driven the growth observed in the economic costs of dementia since the 1990s.
- If the future costs of dementia are to be reduced, China needs a nationwide dementia action plan to develop an integrated health and social care system and to promote primary and secondary prevention.
Why it matters
In China, the yearly cost of dementia was estimated to rise from US$ 0.9 billion in 1990 to US$ 47.2 billion in 2010 and was predicted to reach US$ 114.2 billion by 2030, driven mainly by population ageing and rising dementia prevalence. Informal care, the unpaid work families do, made up 81–94% of the estimated cost between 1990 and 2010, which is why the authors call for a national dementia plan with integrated health and social care. This is a cost-modelling study. It does not test any treatment or prevention, and its 2020 and 2030 figures are projections.
New to this subject? Start with our plain-English guide: Caregiving →
Study details
- Effect sizeor 94.4; 92.9%; 81.3%
- Evidence strengthLow
How this study scored 52/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Bulletin of the World Health Organization) |
| Journal's citation record | 2 / 4 | Bulletin of the World Health Organization: journal h-index 200 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 2 / 5 | 2017 — within 10 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 2 / 3 | Effect reported as a number, without an interval or test |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 5 / 7 | Cited 210 times (OpenAlex, 2026-10-10) |
| Citations per year | 3 / 5 | 19.1 citations a year over 11 year(s) since 2017 |
| Impact for its field and year | 4 / 6 | Cited 8.0× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 3 / 6 | Cited by 10 other studies in this library |
| Still being cited | 3 / 4 | Cited 58 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 3 / 4 | Last-listed author Chengxuan Qiu: h-index 66 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | Karolinska Institutet: institution h-index 1,477 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | OpenAlex lists 4 institution(s) in 2 countries |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 28053361) |
| Free to read | 2 / 2 | Free to read |
| Total | 52 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.2471/blt.15.167726
- PubMed: 28053361
- Original source →
- Free full text: Bulletin of the World Health Organization →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 15.
Later studies that cite this one
10 studies in the alzhub library list this one in their references. Showing the 8 highest-scoring.
Related studies in Caregiving from nearby years
Also tagged “prevalence”
1,225 studies in the library carry the topic tag “prevalence”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,225 tagged studies.